
Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

The deaths of three patients at an alternative medicine clinic in Germany have prompted suspicion of a clinically untested cancer …
Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

Juno Therapeutics (NASDAQ: JUNO) has had its Phase II trial investigating JCAR015 in adult patients with relapsed or refractory B …